KRAS and breast carcinoma: Additionally, Gallegos-Arreola et al. (2021) reported an association between KRAS rs61764370 and HER2 histological type breast cancer, with an OR of 3.4 (95% CI: 1.24–9.84, p = 0.018) [35].